Fulcrum Therapeutics Inc. (FULC)
NASDAQ: FULC
· Real-Time Price · USD
7.25
0.14 (1.97%)
At close: Jun 06, 2025, 1:36 PM
Fulcrum Therapeutics Revenue
Fulcrum Therapeutics reported an annual revenue of $80M, reflecting a 2752.05% growth. For the quarter ending March 31, 2025, Fulcrum Therapeutics generated $0 in revenue.
Revenue (ttm)
$80M
Revenue Growth
2752.05%
Price / Sales Ratio
3.64
Revenue / Employee
$1.78M
Employees
45
Market Cap
391.35M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|